通过通过PTEN/AKT信号通路调节细胞周期,EEF1E1促进结质瘤的扩散
Hongyu Wang1, Ruiqin Han2, Qiao Li1,3
1The Second Medical College of Lanzhou University, Lanzhou, Gansu, China.
Molecular carcinogenesis
|August 17, 2023
概括
该研究显示,EEF1E1的下调抑制了通过影响PTEN/AKT通路和细胞周期进展来抑制质瘤细胞的增殖. 这一发现将EEF1E1定位为质瘤治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞循环调节细胞增殖,并受到PTEN/AKT信号通路的影响.
- 环林相关的蛋白质是细胞循环调节的关键媒介.
- 脑瘤是一种脑瘤,其特点是无法控制的细胞增殖.
研究的目的:
- 研究EEF1E1在质瘤细胞增殖中的作用.
- 阐明EEF1E1影响PTEN/AKT通路和细胞循环的机制.
- 评估EEF1E1作为质瘤的潜在治疗点.
主要方法:
- 进行细胞循环测试以分析细胞循环进展.
- 细胞计数套件-8,殖民地形成和乙基-2'-脱氧氨胺试验被用于评估增殖.
- 动物研究和对大脑切片的共同培养实验进行了验证.
主要成果:
- 发现EEF1E1下调抑制PTEN表达.
- EEF1E1通过抑制PTEN/AKT通路来调节细胞循环相关的蛋白质.
- EEF1E1 knockdown 通过在 G1 和 S 阶段停止细胞来抑制质瘤细胞的增殖.
结论:
- 通过通过PTEN/AKT通路调节细胞循环,EEF1E1 knockdown有效地抑制质瘤细胞的增殖.
- 在质瘤的进展中,EEF1E1起着至关重要的作用.
- EEF1E1代表了治疗质瘤治疗的一个有前途的治疗点.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


